Address:
Tel:
Web: http://www.neuca.pl/en/about-us/neuca-group
NEUCA is a group of financially connected companies offering a wide spectrum of services and products on the healthcare market in Poland. Main fields of activity include wholesale of pharmaceuticals to pharmacies, modern logistics, marketing and advertising services for pharmaceutical market as well as partnership programmes for independent pharmacies, IT services for pharmacies and individual pharmaceutical products.
Within the Capital Group there are several subsidiaries, all employing over 5 thousand people. The company’s headquarters is in Toruń. Two partnership programmes for independent pharmacies associate over 2.5 thousand entities.
The Capital Group is a pharmaceuticals wholesale market leader. Market shares at the end of 2009 amounted to 31.3%. Every day NEUCA reaches 9 thousand pharmacies all over Poland.
NEUCA was set up in 1990 as TORFARM S.A. In 2004 the company debuted on the Warsaw Stock Exchange. Since 2005 the company has become the most active and efficient subject active in the consolidation process of Polish pharmaceutical wholesale market reaching 20% market shares within three years only. The completion of the consolidation took place in mid 2009 with Prosper joining the Group and the market shares consequently growing by another 10%.
The Group operates in four crucial business areas:
WHOLESALE (subsidiary wholesale companies selling pharmaceuticals to pharmacies)
RETAIL (World of Health (Świat Zdrowia) and Good Price Pharmacy (Apteka Dobrych Cen))
OWN PRODUCTS (Synoptis Pharma)
SERVICES ON THE HEALTHCARE MARKET (NEKK marketing agency, ILC informatics company)
Maciej Wieczorek, president of Celon Pharma, discusses the award-winning success of the 2016 IPO on the Warsaw stock exchange and the opportunities this has opened up, as well as investment…
Iwona Skrzekowska-Baran, owner and CEO of Pharm&Med, a young, exciting Polish consultancy that is helping clients to transform evidence, policy insights, and market intelligence into effective market access strategies. She…
Leonardo Maffioli, senior marketing and commercial manager of the fertility and endocrinology division of IBSA, discusses the story of IBSA Poland and the potential of the Polish market for the…
Jacek Glinka, president of Mylan Europe, and Tomasz Buczek, country manager of Mylan Poland, discuss the intricate dynamics of the European and Polish pharmaceutical ecosystem and the steps required to…
Witold Włodarczyk, director general of Polmed (Polish chamber for medical devices), discusses the Polish medical device landscape and the policy surrounding the sector, especially the proposed 2016 reimbursement act. Furthermore,…
Krzysztof Łokaj, general manager of Chiesi Poland, discusses the positioning of the company as they become the absolute leaders in the respiratory field, driven by Fostex® and soon Trimbow®. Furthermore,…
Dariusz Głogowski, country manager of Alvogen Poland, discusses his successful strategy to introduce biosimilars onto the Polish market and the nation’s moves to reward this new wave of generics. Furthermore,…
Agnieszka Grzybowska-Zalewska, general manager of Sanofi Genzyme Poland, reflects on the company’s stable growth over the last few years and the market access challenges they have encountered along the way.…
Dr. Wolfgang Wagner, regional director of Wörwag EU and CEE, highlights the ongoing process of the company to integrate itself within each respective healthcare community so patients can receive better…
Paweł Przewięźlikowski, CEO of Selvita, the largest biotech company between Germany and India, discusses the first-in-class and pioneer Polish molecule, SEL24, and the future game changing molecule, SEL120 – the…
Mieczysław Wośko, president and founder of Polfarmex, a leading Polish company, discusses the key factors behind the enterprise’s successful growth and the movement towards R&D to create their own treatments.…
Michał Mieszkowski, general manager of Angelini Poland, discusses the strategic significance of Poland for the company, as the third largest affiliate within the global company, the company’s impressive product portfolio…
See our Cookie Privacy Policy Here
